Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
REPAIR-ACS: Progenitor Cells in NSTEMI
NCT00711542Phase 2Terminated
- Sponsor
- Universitätsklinikum Frankfurt
- Start
- Sep 2008
- Primary completion
- Dec 2014
- Modality
- Stem Cell Therapies, Adoptive Cell Transfer
- Countries
- 1
01
Overview
A Phase 2 trial of autologous bone marrow-derived progenitor cells in non-ST segment elevation myocardial infarction (NSTEMI), sponsored by Universitätsklinikum Frankfurt. Started Sep 2008; status: terminated.
02
Drugs
autologous bone marrow-derived progenitor cells
03
Conditions
non-ST segment elevation myocardial infarction (NSTEMI)
Beyond the preview
Go deeper on NCT00711542.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00711542.